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DObjective: The optimal timing for neonatal cardiac surgery is unknown. We aimed to determine the relationship
between age at surgery and perioperative outcomes, hypothesizing that earlier intervention would be associated
with lower morbidity and mortality.
Methods: A retrospective review was performed of neonates who had undergone an arterial switch operation,
stage 1 palliation for functional single ventricle, or systemic-to-pulmonary shunt for obstructed pulmonary
blood flow from January 1, 2005, to December 31, 2010. The subjects with clinical indications for delayed
surgery or prematurity were excluded. Age at surgery was evaluated as both a continuous and a categorical
variable. The primary outcome was a composite endpoint of mortality or prolonged intensive care stay.
Results: Of 344 subjects, 286 (77 arterial switch operation, 124 stage 1 palliation, 85 systemic-to-pulmonary
shunt) met the inclusion criteria. In each group, age at surgery was not associated with the primary composite
endpoint. The patients who died after systemic-to-pulmonary shunt had a median age at surgery of 3 days versus
6 days for the survivors (P¼ .04). A similar, but nonsignificant, pattern was seen for patients undergoing arterial
switch operations (4.5 vs 7 days; P ¼ .09). Earlier surgery was not associated with a reduced duration of
vasoactive support, mechanical ventilation, or intensive care unit length of stay in any group. Stage 1 palliation
subjects in the upper age quartile (8 days) at surgery were less likely to require prolonged mechanical
ventilation (P ¼ .03).
Conclusions: Younger age at intervention in the neonatal period was not associated with reduced morbidity or
mortality in any procedural subgroup studied. In our cohort, earlier systemic-to-pulmonary shunt for obstructed
pulmonary blood flow was associated with a greater likelihood of a poor outcome. (J Thorac Cardiovasc Surg
2014;147:1573-9)The outcomes for neonates requiring cardiac surgical
intervention in the first weeks of life have improved greatly
during the previous 3 decades.1,2 However, high mortality
has persisted for certain high-risk procedures such as stage
1 palliation (S1P) of a functional single ventricle.2-4
Furthermore, postoperative complications and marked
healthcare resource usage remain common for these
vulnerable patients. Pediatric cardiac surgeons,
intensivists, and cardiologists have sought to identify
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The Journal of Thoracic and Carinterventions aimed at reducing their frequency, while
also striving to use resources efficiently.
The timing of surgical intervention is a potentially
modifiable variable; however, the effect on outcome is
unknown. Since the addition of prostaglandin infusions to
standard preoperative medical management, it has been
possible to electively schedule most patients with
ductal-dependent lesions in the first days to weeks of life.
Some institutions have recently adopted a preferred practice
of performing complex neonatal operations such as the
arterial switch operation (ASO) for d-transposition of the
great arteries or S1P within the first 72 hours of life.5,6
The foundation for such practice has been predicated on
the concept that the preoperative physiology is inherently
abnormal (eg, pulmonary overcirculation, cyanosis) and
that early repair reduces exposure to these physiologic
insults, resulting in better short- and long-term outcomes.
In addition, if surgery can be performed earlier without
increasing the risk, it will reduce the healthcare costs by
shortening the preoperative period. For patients born at, or
transferred to, the surgical institution within the first 24
hours of life, and those diagnosed prenatally, interventiondiovascular Surgery c Volume 147, Number 5 1573
Abbreviations and Acronyms
ASO ¼ arterial switch operation
ICU ¼ intensive care unit
S1P ¼ stage 1 palliation
SPS ¼ systemic-to-pulmonary shunt
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Dwithin the first 72 hours is feasible if no medical contrain-
dications to surgery are present (eg, sepsis, intracranial
hemorrhage, necrotizing enterocolitis).
The risks and benefits associated with particular
strategies for the timing of neonatal surgical intervention
have not been rigorously assessed. In a study of outcomes
after congenital heart repair at any age, Padley et al2 found
no association between age at surgery and mortality in the
neonatal subgroup. Their result is in contrast to the findings
of Kang et al,7 who described increasing mortality with
decreasing age at intervention in the neonatal period.
However, neither study examined specific subgroups
according to the anatomy and/or procedure performed.
Within our institution, there was a desire to develop a
standard practice of early intervention to optimize the
outcomes and minimize resource usage. However, because
of the relative lack of evidence for an early versus elective
strategy, we performed the present retrospective analysis to
determine whether earlier surgical intervention in the
neonatal period was associated with improved perioperative
outcomes. We tested the hypothesis that earlier intervention
would be associated with a lower likelihood of a composite
morbidity and mortality outcome variable in distinct proce-
dural subgroups. We chose to study 3 procedures—ASO,
S1P, and systemic-to-pulmonary shunt (SPS) for obstructed
pulmonary blood flow—to assess the strength of the
association among groups of patients with different
preoperative physiology and perioperative risk.METHODS
Study Design
We performed a retrospective review of all neonates undergoing ASO,
S1P, or SPS at our institution from January 2005 to December 2010.
Premature infants (gestational age<37 weeks) were excluded. We also
excluded patients from the analysis if a nonelective delay was present in
the timing of surgery, because this would have likely confounded the
association between age at surgery and the clinical outcomes. A thorough
examination was performed to determine the occurrence of medical
contraindications to surgery or the need for additional diagnostic
evaluations. The typical reasons for a nonelective delay included cardiac
arrest or shock preoperatively, infection, or necrotizing enterocolitis. The
institutional review board of the University of Michigan Medical School
approved the study, with a waiver for obtaining informed consent.
Data Collection
Demographic and clinical data were collected for all patients. In
addition, specific anatomic and physiologic variables were collected for
the individual lesion subgroups, because they could affect both the1574 The Journal of Thoracic and Cardiovascular Surdecisions about surgical timing and the eventual outcome. The variables
identified as potential confounders of the association between age at
surgery and outcomes were collected. These included a prenatal diagnosis,
genetic abnormalities, noncardiac anomalies, and certain anatomic and
physiologic characteristics.
The primary outcome variable (poor outcome) was a combined metric
of in-hospital or 30-day out-of-hospital mortality and prolonged post-
operative intensive care (ICU) length of stay. A prolonged ICU stay was
defined as greater than the 75th percentile for the subject’s anatomic sub-
group. Secondary outcomes included ICU mortality, duration of postoper-
ative mechanical ventilation, and total hospital stay. Cardiac arrest,
mechanical circulatory support, hospital-acquired infection, renal failure
requiring dialysis, new neurologic injury (seizure or stroke), and necro-
tizing enterocolitis were also recorded and measured.
Statistical Analysis
The data are presented as frequencies and percentages for categorical
variables and median and interquartile range or mean standard deviation,
as appropriate, for continuous variables. Age at surgery was evaluated as
both a continuous and a categorical variable using cutoffs determined
from the upper quartile (less than upper quartile vs the upper quartile or
more) for each procedure subgroup. The associations between age at
surgery and postoperative outcomes, including a composite poor outcome
for each lesion group, were examined usingWilcoxon rank sum test (age at
surgery as a continuous variable) and chi-square test or Fisher’s exact test
(age at surgery as a categorical variable), as appropriate. Continuous
variables in the postoperative data were also evaluated categorically using
the upper quartile as cutoffs. Additionally, a similar analysis was conducted
to examine the associations between age at surgery and postoperative
outcomes by single- or 2-ventricle anatomy in the SPS group. Finally,
we performed a subgroup analysis to specifically examine the outcomes
in the patients who had undergone surgery within the first 72 hours of
life, consistent with the newer strategies of early intervention at peer
institutions.
Univariate analyses were performed to determinewhether the measured
potential confounders (prenatal diagnosis, weight, genetic abnormalities,
and extracardiac anomalies) were associated with outcome within each
subgroup. Although none of these met the typical requirement for
inclusion in the multivariate models, all with P > .15, we chose to
perform a multivariate analysis controlling for potential confounders
well-supported in previous data to better assess the association of age at
surgery with a poor outcome. All analyses were performed using Statistical
Analysis Systems, version 9.3 (SAS Institute, Cary, NC), using 2-sided
tests of significance at an a level of 0.05.
RESULTS
A total of 344 neonates required intervention (ASO, S1P,
or SPS) during the study period. Of these, 24 patients had a
gestational age of less than 37 weeks, and 34 patients
had had their intervention delayed for various clinical
indications (nonelective delay group). The leading causes
of such delay were cardiac arrest, shock, fever, and
presumed or documented infection. The remaining 286
patients were included in the present analysis (77 ASO,
124 S1P, and 85 SPS).
The demographic and preoperative clinical characteris-
tics of the cohort are listed in Table 1. The subjects in the
S1P group were more frequently diagnosed prenatally and
born at our institution compared with the patients in the
ASO group. The postoperative characteristics of the 3
groups are presented in Table 2. The median age at surgerygery c May 2014










Male gender 51 (66.2) 92 (74.2) 39 (45.9)
Birth weight (kg) 3.41  0.46 3.27  0.52 3.10  0.48
Prenatal diagnosis 26 (33.8) 104 (83.9) 57 (67.1)
Genetic anomaly 3 (3.9) 2 (1.6) 11 (12.9)
Extracardiac anomaly 5 (6.5) 3 (2.4) 18 (17.5)
Born at UM
Yes 19 (24.7) 95 (76.6) 48 (56.5)
No (transferred) 58 (75.3) 29 (23.4) 37 (43.5)
Preoperative
Mechanical ventilation 65 (84.4) 69 (55.6) 38 (44.7)
Duration (d) 5 (3-7) 4.5 (3-6) 3 (2-5)
Vasoactive support 45 (58.4) 64 (51.6) 22 (25.9)
Duration (d) 4 (3-6) 5 (3-6) 2.5 (1-5)
Prostaglandin infusion 74 (96.1) 121 (97.6) 79 (92.9)
Duration (d) 5 (4-7) 6 (4-7) 5 (3-7)
Central venous access 74 (96.1) 120 (96.8) 78 (91.8)
Duration (d) 5 (4-7) 6 (5-7) 5 (3-7)
Data presented as n (%) for categorical variables and mean  standard deviation or
median (interquartile range), as appropriate, for continuous variables. ASO, Arterial
switch operation; S1P, stage 1 palliation; SPS, systemic-to-pulmonary shunt;
UM, University of Michigan.
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Dwas 7 days for those in the ASO group and 6 days for those
in the S1P and SPS groups. Fewer than 25% of each group
underwent surgery within the first 72 hours of life.Arterial Switch Operation
A younger age at surgery was not associated with the
composite poor outcome variable (mortality or prolonged
ICU length of stay) in the ASO group (Table 3). In contrast,
the median age at surgery for the ASO patients with a poor
composite outcome was younger than that of those with a
good outcome, although this failed to reach statistical
significance (5 vs 7 days; P ¼ .06). This pattern was also
true considering mortality alone, but the finding did not
reach statistical significance (P ¼ .09). No measure of
morbidity was significantly associated with age at surgery
in this group. When considering patients who had
undergone surgery within 72 hours (n ¼ 6), no deaths
occurred in this subgroup compared with 4 in the patients
operated after 72 hours of life. However, no significant
difference was found in incidence of the poor outcome or
any of the individual mortality or morbidity metrics.S1P for a Single Ventricle
No association was found between age at surgery and the
composite poor outcome variable for patients undergoing
S1P (Table 3) nor was an association found when analyzing
mortality alone. When analyzing age as a categorical
variable, older age at surgery (upper quartile, 8 days)The Journal of Thoracic and Carwas again protective, because it was associated with a
decreased likelihood of prolonged mechanical ventilation
after S1P (12% of patients with age at surgery 8 days
vs 32% of those with age at surgery<8 days; P ¼ .03;
data not shown). Just as with patients undergoing ASO,
no difference was found in outcomes between those patients
receiving their intervention within 72 hours of birth (n¼ 15)
compared with those who underwent surgery later.
SPS for Obstructed Pulmonary Blood Flow
Just as in the 2 previous groups, age at surgery was not
associated with a composite poor outcome endpoint in the
SPS group (Table 3). However, considering mortality alone
(Table 3), for the subjects undergoing SPS for obstructed
pulmonary blood flow, a significant inverse relationship
was found between age at surgery and both ICU mortality
(P ¼ .01) and in-hospital or within 30 days of surgery
mortality (P ¼ .04), favoring an older age at surgery. This
difference was driven primarily by the difference among
SPS subjects with single ventricle lesions (Table 4). No
ICU, in-hospital, or within 30-day death occurred in
patients with biventricular anatomy requiring SPS. No
measure of morbidity was positively or negatively
associated with age at surgery in patients undergoing SPS.
The in-hospital or within 30-day mortality was significantly
greater for patients operated within 72 hours of life (n¼ 21;
24% vs 5%, P ¼ .02; data not shown). Just as before, this
finding was primarily attributable to patients with single
ventricle anatomy.
Multivariate Analysis
As previously described in the ‘‘Methods’’ section, no
patient or operative variable was associated with the
composite outcome (all P> .15) on univariate analysis.
We, therefore, constructed a model to test the indepen-
dence of a potential association between age at surgery
and the composite outcome variable, controlling for the
patient variables commonly associated with outcome.
The number of covariates was adjusted for each procedural
subgroup according to the number of outcomes observed.
The models included birth weight, prenatal diagnosis,
and genetic syndrome and/or extracardiac anomaly. In
addition, for the SPS group, the model included ventricular
anatomy (single vs double). Age at surgery was not
significantly associated with the composite endpoint
in any of the procedural subgroups. Furthermore, no
association was found between age at surgery and pro-
longed mechanical ventilation, prolonged postoperative
vasoactive support, or a prolonged hospital length of
stay. For patients undergoing SPS, age at surgery was
associated with mortality in the multivariate model; for
every 1-day increase in age at surgery, the odds of death
were decreased by 73% (adjusted odds ratio, 0.27; 95%
confidence interval, 0.09-0.82).diovascular Surgery c Volume 147, Number 5 1575
TABLE 2. Postoperative characteristics and outcomes stratified by group
Characteristic ASO (n ¼ 77) S1P (n ¼ 124) SPS (n ¼ 85)
Age at surgery (d) 7 (4-8) 6 (5-8) 6 (4-7)
Interval from hospital admission to surgery (d) 5 (3-7) 6 (4-7) 4 (2-6)
Intraoperative
Cardiopulmonary bypass time (min) 143 (124-173) 89 (73.5-126.5) 43 (0-71)
Aortic crossclamp time (min) 75 (55-89) 39 (35-45) 0 (0-4)
Hypothermic circulatory arrest (n) 7 (9.1) 123 (99.2) 4 (4.7)
Postoperative
ECMO 4 (5.2) 27 (21.8) 5 (5.9)
Seizure or stroke 3 (3.9) 12 (9.7) 2 (2.4)
Dialysis 3 (3.9) 9 (7.3) 0 (0.0)
Delayed sternal closure 16 (20.8) 120 (96.8) 9 (10.6)
If yes, duration of initial open chest (d) 3 (2.5-5) 4 (2.5-6) 3 (3-3)
Place opened
OR 13 (81.2) 120 (100.0) 5 (55.6)
PCTU 3 (18.8) 0 (0.0) 4 (44.4)
Postoperative NEC 0 (0.0) 9 (7.3) 10 (11.8)
Surgical site infection 1 (1.3) 4 (3.2) 1 (1.2)
Catheter-associated blood stream infection 0 (0.0) 3 (2.4) 1 (1.2)
Postoperative CPR 5 (6.5) 13 (10.5) 5 (5.9)
Duration of postoperative vasoactive support (d) 4 (3-5) 7 (5-11) 3 (2-5)
Duration of initial postoperative intubation (d) 4 (3-5) 6 (4-10) 4 (3-5)
Initial postoperative ICU length of stay (d) 6 (5-9) 9.5 (7-14) 5 (4-7)
Total hospital length of stay (d) 11 (9-16) 20 (14-36.5) 12 (9-18)
ICU deaths 4 (5.2) 19 (15.3) 4 (4.7)
Died in hospital or within 30 d of surgery 4 (5.2) 23 (18.5) 8 (9.4)
Composite outcome*
Poor outcome 21 (27.3) 50 (40.3) 23 (27.1)
Good outcome 56 (72.7) 74 (59.7) 62 (72.9)
Data presented as n (%) for categorical variables and median (IQR) for continuous variables. ECMO, Extracorporeal membrane oxygenation; OR, operating room;
PCTU, pediatric cardiothoracic intensive care unit; NEC, necrotizing enterocolitis; CPR, cardiopulmonary resuscitation; ICU, intensive care unit; ASO, arterial switch operation;
S1P, stage 1 palliation; SPS, systemic-to-pulmonary shunt. *Defined as a poor outcome if patient died in hospital or within 30 d after surgery or greater than 75th percentile on the
initial postoperative ICU length of stay and as good outcome otherwise.




We have shown in the present cohort that an earlier age at
surgery was not associated with improvement in a
composite clinical outcome of mortality or prolonged ICU
length of stay for neonates undergoing S1P, ASO, or SPS,
as hypothesized. The findings for age at surgery compared
with mortality alone demonstrated the opposite effect for
SPS subjects. In subjects undergoing SPS, a significant
survival benefit was found for older age at surgery in both
ICU and in-hospital or 30-day mortality that was primarily
driven by those with single ventricle anatomy. Similarly, a
suggestion was found for older age being associated with
lower mortality for subjects undergoing ASO. No such
associations were apparent for subjects undergoing S1P.
A younger age at surgery was also not associated with
decreased morbidity in any subgroup.
Our question was motivated in part because some
pediatric cardiac surgical centers have adopted a practice
of taking neonates to the operating room in the first 48 to
72 hours of life, absent clinical contraindications. Although
this has not been our institution’s practice, theoretical1576 The Journal of Thoracic and Cardiovascular Surbenefits exist to support such a strategy. For instance, earlier
intervention in the neonatal period would reduce patient
exposure to cyanosis, excessive pulmonary blood flow,
and the complications associated with typical intensive
care practices, such as indwelling catheters and mechanical
ventilation. In addition, if no data suggest that clinical
risks are associated with early neonatal intervention, a
straightforward argument for greater cost-effectiveness
would naturally follow. Because few previous studies
have addressed the risks and benefits of elective early
neonatal intervention, our investigation was designed to
explore these knowledge gaps.
Previous data on the timing of neonatal surgery have
focused mostly on the risk of mortality for patients who
present late for surgery in the neonatal period with
previously undiagnosed disease (eg, single ventricle and
d-transposition of the great arteries). These studies have
demonstrated that older age at surgery confers an increased
risk of morbidity and mortality.8-13 However, patients
presenting in the second half of the first month of life or
later are likely to be inherently different from the standardgery c May 2014
TABLE 3. Association between age at surgery and postoperative morbidity and mortality stratified by group (n ¼ 286)
Postoperative characteristics
ASO (n ¼ 77) S1P (n ¼ 124) SPS (n ¼ 85)
Age (d) P value* Age (d) P value Age (d) P value
Duration of vasoactive support (d) .07 .19 .28
 Upper quartile 5 (4-8) 6 (5-7) 6 (4-8)
<Upper quartile 7 (5-9) 6 (5-8) 5 (3-7)
Length of initial intubation (d) .95 .07 .40
 Upper quartile 5 (4-9) 6 (5-7) 6 (4-7)
<Upper quartile 7 (4-8) 7 (5-8) 5 (3-7)
Initial ICU length of stay (d) .41 .21 .25
 Upper quartile 5 (4-8) 6 (5-7) 6 (4-7)
<Upper quartile 7 (4.5-8.5) 6 (5-8) 5 (3-7)
Total hospital length of stay (d) .13 .26 .73
 Upper quartile 5 (4-7) 6 (5-7) 6 (4-7)
<Upper quartile 7 (4.5-9) 6 (5-8) 6 (3-7)
ICU death .09 .78 .01
Yes 4.5 (4-5) 6 (4-7) 3 (2.5-3)
No 7 (5-8) 6 (5-8) 6 (4-7)
Died in hospital or within 30 d of operation .09 .95 .04
Yes 4.5 (4-5) 7 (4-7) 3 (3-5)
No 7 (5-8) 6 (5-8) 6 (4-7)
Composite outcomey .06 .17 .93
Poor outcome 5 (4-7) 6 (4-7) 6 (3-7)
Good outcome 7 (5-9) 6 (5-8) 6 (4-7)
Data presented as median (interquartile range). ASO, Arterial switch operation; S1P, stage 1 palliation; SPS, systemic-to-pulmonary shunt; ICU, intensive care unit. *P value from
Wilcoxon rank sum test. yDefined as a poor outcome if the patient died in hospital or within 30 days of surgery or greater than the 75th percentile of the initial postoperative ICU
length of stay, and a good outcome, if otherwise.
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Dpatients diagnosed prenatally or shortly after birth. Older
neonates are more likely to present in the setting of
cardiovascular collapse (eg, single ventricle) or have
anatomic and physiologic characteristics that have
masked the cardinal symptoms of complex congenital
heart disease. Therefore, these previous analyses of
outcomes across a wide spectrum of patient ages
(including patients who were not neonates) could not
provide insight into the relative risks and benefits of early
surgery (48-72 hours after birth). Direct comparisons
between neonates undergoing early intervention and those
scheduled electively in the first 2 weeks of life, such as
were presented in the present study, are necessary to
address this uncertainty.
Although a relative paucity of data has focused on this
question, some data from the current era have supported
the findings from our investigation. For example, a recent
analysis of patients undergoing S1P from the Society of
Thoracic Surgeons Pediatric and Congenital Database
showed that age at surgery was not associated with the
likelihood of developing a postoperative complication.14
However, other work has suggested there could be subtle
morbidities associated with even a short delay before
intervention. Petit et al15 demonstrated that a longer interval
to surgery was a risk factor for postoperative periventricular
leukomalacia in a small series of neonates with d-transposi-
tion of the great arteries undergoing ASO. Many futureThe Journal of Thoracic and Carefforts are necessary to explore the utility of an early
surgery strategy. In doing so, surgeons, intensivists, and car-
diologists seeking to improve the results for neonates
requiring surgery should investigate a broad range of short-
and long-term outcome metrics to assess these risks and
benefits.
In contrast to our investigation, some preliminary
evidence exists to support the benefits of early surgery.
One of the few studies to specifically examine the
outcomes of patients undergoing surgery in the first
72 hours of life was that by Chasovskyi et al,6 in which
neonates undergoing ASO were allocated to an operation
in the first hours of life versus at a mean age of 7.5 days.
Although the patients had different blood priming
strategies for cardiopulmonary bypass, the cohort
undergoing surgery on the first day of life experienced
significantly shorter hospital stays, on average, and no
suggestion was found of increased morbidity or mortality
in this cohort. The hospital stay was reduced by an
average of approximately 4 days. In our study, a small
percentage of patients underwent surgery within the first
72 hours of life. We found no suggested benefit or harm
from ‘‘early’’ intervention in patients undergoing ASO
or S1P; however, statistically significant increases were
found in mortality for patients with single ventricle
anatomy and obstructed pulmonary blood flow under-
going SPS.diovascular Surgery c Volume 147, Number 5 1577
TABLE 4. Association between age at surgery and postoperative
morbidity and mortality stratified by ventricular anatomy for
patients undergoing SPS (n ¼ 85)
Postoperative characteristics
Ventricular anatomy






Duration of vasoactive support (d) .26 .25
 Upper quartile 6 (4-7) 7 (6-11)
<Upper quartile 4 (3-6) 6 (4-7.5)
Length of initial intubation (d) .51 .76
 Upper quartile 5 (4-7) 6.5 (5-8)
<Upper quartile 4 (3-6) 6 (4-8.5)
Initial ICU length of stay (d) .24 .51
 Upper quartile 5.5 (4-7) 7 (5.5-8)
<Upper quartile 4 (3-6) 6 (4-8.5)
Total hospital length of stay (d) .21 .36
 Upper quartile 6 (4-7) 6 (3-8)
<Upper quartile 4 (3-6) 6 (4-9)
ICU death .02 NA
Yes 3 (2.5-3) NA
No 5 (3-7)
Died in hospital or within 30 d
of surgery
.03 NA
Yes 3 (3-3) NA
No 5 (3-7)
Composite outcomey .54 .43
Poor outcome 4 (3-6) 7 (5-9)
Good outcome 4.5 (3-7) 6 (4-8)
Data presented as median (interquartile range). NA, Not applicable; SPS, systemic-to-
pulmonary shunt; ICU, intensive care unit. *P value from Wilcoxon rank sum test.
yDefined as a poor outcome if the patient died in hospital or within 30 days of surgery
or greater than the 75th percentile of the initial postoperative ICU length of stay, and a
good outcome if otherwise.
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DPotentially important implications exist for the organiza-
tion of cardiac surgical programs based on the findings
related to questions around the timing of neonatal surgery.
At our institution, just as at many others, patients are
frequently assigned to a particular surgeon because of a
targeted referral or preoperative consultation. When
neonates are born, the surgeon or operating room time
might not be immediately available in the first 72 hours of
that child’s life. In particular, at high-volume facilities
with busy ICUs and ward units, it is not an easy logistical
matter to cancel and reschedule elective or semielective
procedures, nor is it financially trivial to open operating
rooms at off-hours to accommodate a new neonate.
Therefore, a comprehensive institutional commitment
would be necessary to adopt a strategy of early intervention
in the neonatal period. This underscores the need to
rigorously examine the potential risks and benefits of early
surgery. Our data do not suggest a benefit to early surgical
intervention in these patients, and, as such, we have not
modified our practice of elective scheduling, according to
surgeon and operating room availability, for stable patients1578 The Journal of Thoracic and Cardiovascular Surawaiting ASO, S1P, or SPS for obstructed pulmonary blood
flow.
Our study findings have important limitations that should
be considered. The greatest potential threat to the validity of
our findings is that the age at surgery for these subjects was
not random. We reviewed the records exhaustively to
determine whether clinical indications existed for earlier
or delayed surgery. We excluded such patients to minimize
the effect of confounding by indication on our exposure
variable of age at surgery. Although we made every effort
to include only patients who were truly scheduled
electively, we could not exclude the possibility that some
patients underwent surgery earlier or later because of a
particular clinical risk factor that affected their eventual
outcome. Only a randomized study design can overcome
this limitation. We were also limited because only 25% of
patients had undergone their operation in the first 72 hours
of life, reducing our analytic power for this subgroup of
interest. Finally, we had no measure of the patient’s
preoperative physiologic state. Differences could exist in
the risks for patients with evidence of marked physiologic
derangement in the preoperative period and, when
comparing patients with surgery at different ages, it
might be an important covariate. Just as with any
single-institution study, our results are not necessarily
generalizable to institutions with different case mix and
resources.
CONCLUSIONS
In the present exploratory analysis, we found no evidence
to suggest that an earlier age at surgery is associated with
better clinical outcomes in a composite of mortality or
prolonged ICU length of stay for neonates undergoing
ASO, S1P, or SPS. Mortality alone had a significant inverse
relationship with age at surgery for SPS subjects, with a
similar trend for ASO patients. From these data, we cannot
make definitive recommendations for institutional best
practice. It is possible, or even likely, that age at surgery
has different effects in specific subgroups of lesions,
making a single blanket policy for optimal age at surgery
impossible. Multi-institutional registries such as the Society
of Thoracic Surgeons database are ideal for an analysis to
confirm our findings or, alternatively, to suggest a future
experimental or quasiexperimental study design to examine
the question further.
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